Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Cost of Care
Fixing the Obamacare ‘Glitch’ That Pushed One Couple to Divorce
The Biden administration is trying to close a gap in the Affordable Care Act that blocks 5 million people from getting affordable health care.
MRIs, Mammograms and the Risk of Breast Cancer Screening Cascades of Care
Stacie Dusetzina shares new research on how much extra care comes after different kinds of breast cancer screenings.
High-Price Drugs Out of Reach for Many on Medicare
Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Pain, Fear and Waste: The Costs of Unnecessary Care
We explore cascades of care — how a clinician’s desire to be thorough can snowball into a harmful spiral of unnecessary care.
Ways to Save in Budget Busting Medicare Part B
Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
State AGs Are Doing Work on Drug Pricing
Erin Fuse Brown writes about a new article highlighting the role of state attorneys general on improving drug price affordability.
